Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Nano‐optogenetic immunotherapy

Clinical and Translational Medicine(2022)10.1002/ctm2.1020Source: DataRank Database

Nano‐optogenetic immunotherapy is a research paper published in Clinical and Translational Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.30)OA: goldTopics (53)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Xiaoxuan Liu ORCID,Gang Han ORCID,Yubin Zhou ORCID,Kai Huang ORCID

Live enrichment

PubMed:36101937 PMC:PMC9471049 OpenAlex:https://openalex.org/W4295752650

National Institutes of Health

Grant: R01CA232017

Cancer Prevention and Research Institute of Texas

Grant: RP210070

Welch Foundation

Grant: BE‐1913‐20220331

National Institutes of Health

Grant: 5R01CA232017-04

NanoOptogenetic immunotherapy for B cell lymphoma

FWCI

1.30

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1002/ctm2.1020

publisherhttps://doi.org/10.1002/ctm2.1020

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1020

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/ctm2.1020

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36101937

Fields of Study

CAR-T cell therapy researchNanowire Synthesis and ApplicationsImmunotherapy and Immune Responses0301 basic medicine0303 health sciences03 medical and health sciencesHumansImmunologic FactorsImmunotherapyImmunotherapy, AdoptiveNeoplasmsReceptors, Antigen, T-CellT-LymphocytesTumor MicroenvironmentUnited States

MeSH Terms

HumansImmunologic FactorsImmunotherapyNeoplasmsReceptors, Antigen, T-CellT-LymphocytesUnited StatesImmunotherapy, AdoptiveTumor Microenvironment

Keywords

Chimeric antigen receptorCytokine release syndromeImmunotherapyMedicineT cellCancer researchImmune systemCell therapyTumor microenvironmentCancer immunotherapyCancerImmunologyCellInternal medicineBiologybiophotonicsNanotechnologyOptogeneticsCar T CellMedicine (General)T-LymphocytesReceptors, Antigen, T-CellImmunotherapy, AdoptiveUnited StatesR5-920NeoplasmsCommentaryHumansImmunologic Factors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being